PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China flag China · Delayed Price · Currency is CNY
37.68
+1.85 (5.16%)
Last updated: Jul 14, 2025
72.05%
Market Cap5.16B
Revenue (ttm)583.17M
Net Income (ttm)25.39M
Shares Out137.54M
EPS (ttm)0.18
PE Ratio214.13
Forward PE113.58
Dividend0.43 (1.15%)
Ex-Dividend DateJul 4, 2025
Volume11,176,293
Average Volume8,278,216
Open35.87
Previous Close35.83
Day's Range35.87 - 38.72
52-Week Range18.41 - 45.40
Beta1.06
RSI59.31
Earnings DateAug 28, 2025

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. operates as a CRO, CDMO, and CMO service provider of drug discovery in China. It also manufactures APIs and key intermediates. The company offers preclinical services. In addition, the company manufactures small molecule related medicine. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,004
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301230
Full Company Profile

Financial Performance

In 2024, SHE:301230's revenue was 544.47 million, an increase of 11.18% compared to the previous year's 489.72 million. Earnings were 17.08 million, a decrease of -54.59%.

Financial Statements

News

There is no news available yet.